Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 12 Mar 2025

Operational procedure sharing pathway in veno-occlusive disease: a Delphi consensus-based recommendations

in Hematologic Malignancies

Francesca Bonifazi
Federico Ravaioli
Anna Paola Iori
Giuseppe Milone
Attilio Olivieri
Arcangelo Prete
Domenico Russo
Stella Santarone
Simona Sica
Marco Zecca

Frontiers in Oncology

doi 10.3389/fonc.2025.1498782

535 views

Systematic Review

Published on 12 Mar 2025

Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: a systematic literature review

in Hematologic Malignancies

Francesca Gay
Elena Zamagni
Craig Emmitt Cole
Christof Scheid
Malin Hultcrantz
Justyna Chorazy
Ike Iheanacho
Anuja Pandey
Jacopo Bitetti
Natalie Boytsov

Frontiers in Oncology

doi 10.3389/fonc.2025.1550644

1,462 views

Original Research

Published on 07 Mar 2025

Anemia and blood transfusions in myelofibrosis: economic and organizational impact on Italian patients, caregivers and hospitals

in Hematologic Malignancies

Francesca Palandri
Alessandro Inzoli
Antonella Barone
Daniela Dordoni
Elisa Formenti
Giorgio Corradini D’Elia
Victoria Lucia Rabsiun Aramburu
Giuseppe Alberto Palumbo
Massimo Breccia

Frontiers in Oncology

doi 10.3389/fonc.2025.1549023

1,175 views

Original Research

Published on 06 Mar 2025

Associations of ANGPT2 expression and its variants (rs1868554 and rs7825407) with multiple myeloma risk and outcome

in Hematologic Malignancies

Sylwia Popek-Marciniec
Wojciech Styk
Sylwia Chocholska
Aneta Szudy-Szczyrek
Katarzyna Sidor
Grazyna Swiderska-Kolacz
Marek Hus
Joanna Czerwik-Marcinkowska
Szymon Zmorzynski

Frontiers in Oncology

doi 10.3389/fonc.2025.1468373

546 views

Original Research

Accepted on 05 Mar 2025

Complex causal association between genetically predicted 731 immunocyte phenotype and leukaemia: A bidirectional Two-sample mendelian randomization analysis

in Hematologic Malignancies

Chenyang Fan
Pengying Yuan
Weifeng Zhang
Haijing Chen
Xinli Zhou
Yucheng Zhang
Gengda Zhu
Chengyulong Zheng
Lixiang Yan
Zhexin Shi

Frontiers in Oncology

doi 10.3389/fonc.2025.1435783

109 views

Review

Published on 05 Mar 2025

Lipid metabolism in multiple myeloma: pathogenesis, therapeutic opportunities, and future directions

in Hematologic Malignancies

Huiquan Wang
Jiafeng Zhang
Hefei Ren
Lei Chen
Jigang Ren
Chang Liu
Hongkun Wu
Lin Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1531928

743 views

Review

Published on 03 Mar 2025

Advancing the understanding and management of angioimmunoblastic T-cell lymphoma: insights into its pathogenesis, clinical features, and emerging therapeutic strategies

in Hematologic Malignancies

Yurou Xing
Junmeng Huang
Yi Zhang
Yongsheng Wang
Shaochong Qi

Frontiers in Oncology

doi 10.3389/fonc.2025.1479179

1,044 views

Original Research

Published on 03 Mar 2025

Retrospective study of chidamide-containing regimens as maintenance therapy among T- and NK-cell lymphoma patients

in Hematologic Malignancies

Tao Hai
Wanchun Wu
Kexin Ren
Na Li
Liqun Zou

Frontiers in Oncology

doi 10.3389/fonc.2025.1507418

411 views

Original Research

Published on 28 Feb 2025

Identification of subgroups of early-stage mycosis fungoides patients with increased itch and impaired quality of life

in Hematologic Malignancies

Julia Nenonen
Anna H. Winther
Pontus Jonsson
Lina U. Ivert
Hanna Brauner

Frontiers in Oncology

doi 10.3389/fonc.2025.1524353

551 views

Original Research

Published on 27 Feb 2025

Tumor gene expression signatures associated with outcome in large B−cell lymphoma treated with CD19-directed CAR T−cell therapy (axicabtagene ciloleucel)

in Hematologic Malignancies

Yuan Tian
Justin Budka
Frederick L. Locke
Jason R. Westin
Christina To
Gayatri Tiwari
Daqin Mao
Davide Bedognetti
Rhine R. Shen
Jorge Andrade

Frontiers in Oncology

doi 10.3389/fonc.2025.1519473

1,655 views

Original Research

Published on 26 Feb 2025

Prognostic impact of initial platelet count and post-induction platelet recovery in elderly AML patients: associated with circulating cytokines

in Hematologic Malignancies

Chun Ling
Neng-Neng Cao
Xiao-Wei Niu
Shi-Yun Xu
Wen-Yu Gong
Wen-Qiang Bao
Qi-Chuan Jin
Yin Wang
Jing Wu
Chang-Zhi Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1534158

658 views

Editorial

Published on 26 Feb 2025

Editorial: MDS: new scientific and clinical developments

in Hematologic Malignancies

Sabine Blum
Argiris Symeonidis
Ulrich Germing

Frontiers in Oncology

doi 10.3389/fonc.2025.1568681

621 views

Case Report

Published on 25 Feb 2025

Mast cell leukemia: a rare case report and literature review

in Hematologic Malignancies

Lu Tian
Xiang Yan
Shaodan Tian
Yang Shen
Qiuyue Fan

Frontiers in Oncology

doi 10.3389/fonc.2025.1537301

581 views

Case Report

Published on 24 Feb 2025

Case Report: A case series on histiocytic sarcoma – various clinical features and patient outcomes

in Hematologic Malignancies

Hohyung Nam
Gi-June Min
Tong Yoon Kim
Youngwoo Jeon
Seok-Goo Cho

Frontiers in Oncology

doi 10.3389/fonc.2025.1505737

737 views

Original Research

Published on 21 Feb 2025

Exploration of risk factors and characteristics of COVID-19 infection among patients with hematological malignancies in Suzhou, China: a retrospective study

in Hematologic Malignancies

Yao Yao
Wenjuan Di
Fangkai He
Bin Liu
Xue Chen
Xiaojun Guan
Zhou Huang
Ying Wang
Depei Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1487516

808 views

Original Research

Published on 21 Feb 2025

Association of ANA and SSA autoantibodies with progression-free survival in multiple myeloma: a retrospective cohort study

in Hematologic Malignancies

Jiafeng Zhang
Hefei Ren
Lei Chen
Xin Wang
Huiquan Wang
Hongkun Wu
Lin Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1529678

596 views